- |||||||||| Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds (clinicaltrials.gov) - Feb 12, 2015 P=N/A, N=1421, Completed, Recruiting --> Completed | N=100 --> 36 | Trial primary completion date: Jun 2012 --> Oct 2012 Active, not recruiting --> Completed | N=1906 --> 1421 | Initiation date: Jul 2008 --> Jul 2005 | Trial primary completion date: Nov 2013 --> May 2013
- |||||||||| rifampicin/isoniazid/ethambutol/pyrazinamide / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: Essentiality of INH in TB Therapy (clinicaltrials.gov) - Feb 11, 2015 P2a, N=60, Not yet recruiting, Trial primary completion date: Nov 2014 --> Nov 2015 N=45 --> 60 | Initiation date: Jul 2014 --> Apr 2015 | Trial primary completion date: May 2015 --> Sep 2015
- |||||||||| Enrollment open, Trial primary completion date: Evaluation of Enhanced Syphilis Screening Among HIV-positive Men (clinicaltrials.gov) - Feb 6, 2015
P=N/A, N=3131, Recruiting, Trial primary completion date: Jan 2015 --> Jul 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Jul 2017
- |||||||||| TicoVac (tick-borne encephalitis vaccine, whole Virus inactivated) / Pfizer
Trial primary completion date: Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (clinicaltrials.gov) - Feb 3, 2015 P2, N=160, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> May 2015 Trial primary completion date: Jan 2020 --> Jan 2030
- |||||||||| Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD)
Phase classification, Pneumococcal vaccines: A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) (clinicaltrials.gov) - Jan 29, 2015 P3, N=130, Completed, Recruiting --> Terminated | Trial primary completion date: Aug 2015 --> Jan 2015; Overall study status is changed to "Terminated" due to low enrollment Phase classification: P1 --> P3
- |||||||||| Trial primary completion date: Prevention of GBS Colonization Via Immunity (clinicaltrials.gov) - Jan 28, 2015
P2, N=667, Completed, Trial primary completion date: Oct 2014 --> Jul 2015 Trial primary completion date: Feb 2008 --> Dec 2008
- |||||||||| Enrollment open, Enrollment change, Trial primary completion date: Peristeen Bowel Irrigation System in Cauda Equina (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=15, Recruiting, Trial primary completion date: Feb 2008 --> Dec 2008 Active, not recruiting --> Recruiting | N=10 --> 15 | Trial primary completion date: Dec 2014 --> Aug 2015
- |||||||||| Trial completion: Prevention of GBS Colonization Via Immunity (clinicaltrials.gov) - Jan 26, 2015
P2, N=667, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Feb 2016 Active, not recruiting --> Completed
|